Indiana's only legal psychedelic

Ketamine is the only one you can legally receive in Indiana today. Psilocybin, MDMA, ayahuasca and the rest are still Schedule I here — no exceptions, no medical carve-out, no waiting list you can join. Here is exactly where each one stands, who decides, and what is actually moving.

Federal scheduling sets the floor. A handful of states have built their own programs on top of it. Indiana has not.

FDA-approved as an anesthetic since 1970, prescribed off label for depression, anxiety and PTSD. Legal in a clinic, under a physician.

FDA-approved specifically for treatment-resistant depression. Offered at certified sites, and often covered by insurance.

Indiana funds research on it but has created no legal access. No service centers, no medical exemption, no way to sign up.

Refiled with the FDA in August 2026 after a 2024 rejection. Not approved anywhere in the United States.

Narrow federal religious-use exemptions exist for specific churches. They do not create general access in Indiana.

No state program and no clinical pathway in Indiana. Ibogaine also carries real cardiac risk.

Indiana did something real here, and it gets misreported constantly, so here it is precisely.

In 2024 the General Assembly passed Senate Bill 139, creating the Therapeutic Psilocybin Research Fund. In 2026 the state directed $300,000 to Indiana University School of Medicine for a clinical trial in treatment-resistant depression and substance use disorder, with a focus on veterans and first responders. Participants receive a single dose alongside several weeks of psychotherapy.

That is a funded clinical trial. It is not legalization. It does not make psilocybin available to you, to us, or to any clinic in the state. If someone tells you Indiana legalized mushrooms — and especially if they are selling something — they are wrong.

Trial participation is decided by the researchers running it, against their own eligibility criteria. We are not affiliated with the study and we cannot refer you into it.

No. Legality is not dose-dependent. A microdose of psilocybin is the same Schedule I substance as a full dose, and Indiana has no exception for either. The same goes for LSD.

Products sold openly as “legal microdoses” are usually something else entirely — amanita muscaria, kava, or a blend of herbs with no psychedelic action at all. That is a different conversation, and we wrote it up on our plant medicine page.

Ketamine was never Schedule I. It has been an FDA-approved anesthetic since 1970, with decades of safety data behind it in operating rooms and emergency departments. It sits in Schedule III, which means it can be prescribed.

Using it for depression is off-label prescribing — the drug is approved, the specific use is not on the original label. That is ordinary medicine, not a loophole, and a great deal of psychiatry works this way. It is also why insurers will not pay for it, which we explain on the cost page.

That single distinction is the whole reason a clinic like ours can operate in Greenwood while a psilocybin clinic cannot. If you want the clinical detail, start with IV ketamine therapy.

Dated honestly, as of September 2026. Anyone giving you a confident approval date is guessing.

The FDA granted Compass Pathways a rolling review for psilocybin (COMP360) in treatment-resistant depression, plus a national priority voucher that shortens review time after filing. Not approved. Closer than any psychedelic has been.

MDMA-assisted therapy for PTSD was refiled with the FDA, two years after the first application was rejected. Not approved, and no announced decision date.

Oregon runs the only fully operational state psilocybin services program in the country. Colorado has licensed healing centers. New Mexico’s medical model is targeted for the end of 2027. Indiana is on none of these lists.

Co-founder, AlphaOmega Wellness · Board-certified psychiatric nurse practitioner · Psychedelic-assisted therapy certified through the Integrative Psychiatry Institute

The legal picture moves faster than any website can. I cover psychedelic medicine and research in real time — what the studies actually found, what the filings and the bills actually mean, and what any of it changes for people here in Indiana.

YouTubeMegan Bonney | Brain Health & Mental HealthInstagram@megan_pmhnp

Some people decide to hold on until psilocybin is approved. Sometimes that is a reasonable call. Often it is a way of putting off a decision that is hard to make.

Nobody knows the approval date. Nobody knows what the label will say, who will qualify, how many certified sites will exist in Indiana in the first year, or what it will cost. The honest question is not which molecule is most exciting — it is what is available to you now, whether it fits your situation, and what another year of waiting would cost you.

That is a conversation, not a sales pitch, and it can end with us telling you this is not the right thing for you.

“The biggest thing I see is the drive in myself to want to better myself, the motivation. Now I have the drive to push through the thoughts that it’s not going to work and make it happen.”

— T.L.

Individual experiences vary.

A free consult, about thirty minutes, with our team rather than a call center. You will leave knowing whether ketamine therapy is a reasonable fit for your situation — and if it is not, we will tell you what we would look at instead.